DermWire TV

Episodes 1-16 of 149

DermwireTV: Deucravacitinib Maintains Efficacy in PsO at 3 Years
DermwireTV: Deucravacitinib Maintains Efficacy in PsO at 3 Years
DermWire TV
DermwireTV: Deucravacitinib Maintains Efficacy in PsO at 3 Years
DermwireTV: DermaRite Issues Recall for Several Hand Soaps
DermwireTV: DermaRite Issues Recall for Several Hand Soaps
DermWire TV
DermwireTV: DermaRite Issues Recall for Several Hand Soaps
DWTV Extra: GPP Awareness Day
DWTV Extra: GPP Awareness Day
DermWire TV
DWTV Extra: GPP Awareness Day
DWTV Extra: DermLink Scholars Founder Dr. Kelly Frasier
DWTV Extra: DermLink Scholars Founder Dr. Kelly Frasier
DermWire TV
DWTV Extra: DermLink Scholars Founder Dr. Kelly Frasier
- Kelly Frasier, DO, MS, CRC
- Alina Bridges, DO, FAAD
DWTV Extra: Remembering Dr. Robert Sidbury
DWTV Extra: Remembering Dr. Robert Sidbury
DermWire TV
DWTV Extra: Remembering Dr. Robert Sidbury
DermwireTV: Pharma Partnership Boosts Spesolimab, Plus More
DermwireTV: Pharma Partnership Boosts Spesolimab, Plus More
DermWire TV
DermwireTV: Pharma Partnership Boosts Spesolimab, Plus More
Research Highlights Disparities in AD Care
Research Highlights Disparities in AD Care
DermWire TV
Research Highlights Disparities in AD Care
Nemluvio Shows Efficacy in AD
Nemluvio Shows Efficacy in AD
DermWire TV
Nemluvio Shows Efficacy in AD
FDA Grants Interchangeability to HADLIMA
FDA Grants Interchangeability to HADLIMA
DermWire TV
FDA Grants Interchangeability to HADLIMA
DWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
DWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
DermWire TV
DWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
- Melinda Gooderham, MSc, MD, FRCPC
Study Examines Socioeconomic Status and HS Diagnosis
Study Examines Socioeconomic Status and HS Diagnosis
DermWire TV
Study Examines Socioeconomic Status and HS Diagnosis
DWTV Extra: Image-Guided SRT Consensus
DWTV Extra: Image-Guided SRT Consensus
DermWire TV
DWTV Extra: Image-Guided SRT Consensus
- Jacob Scott, MD
First Cell-Based Gene Therapy for RDEB
First Cell-Based Gene Therapy for RDEB
DermWire TV
First Cell-Based Gene Therapy for RDEB
Dupixent Approved for Spontaneous Urticaria
Dupixent Approved for Spontaneous Urticaria
DermWire TV
Dupixent Approved for Spontaneous Urticaria
Long-Term Bimzelx Data Presented
Long-Term Bimzelx Data Presented
DermWire TV
Long-Term Bimzelx Data Presented
DWTV Extra: Culturally Conscious Dermatology
DWTV Extra: Culturally Conscious Dermatology
DermWire TV
DWTV Extra: Culturally Conscious Dermatology

Prev
1
2
3
…
9
10
Next

1/6